Natraj Proteins re-appoints Sharad Kumar Jain as Executive Director
- Sharad Kumar Jain re-appointed as Whole-time Director and Executive Director effective October 1, 2026
- Appointment approved for a period of three years during the 35th Annual General Meeting
- Voting results showed 99.9999% support for all four resolutions passed at the meeting
- Jain brings 39 years of experience in the soya industry and real estate business

*this image is generated using AI for illustrative purposes only.
Natraj Proteins Limited shareholders have approved the re-appointment of Sharad Kumar Jain as Whole-time Director and Executive Director. The appointment is effective from October 1, 2026, for a period of three years.
The decision was ratified during the company’s 35th Annual General Meeting held on September 29, 2026. All four resolutions placed before the shareholders were passed with the requisite majority, reflecting strong shareholder confidence in the current leadership structure.
Leadership continuity
Sharad Kumar Jain (DIN: 02757935) is one of the core promoters of the company. He holds a bachelor’s degree in science and brings 39 years of experience in the soya industry and real estate business. In his new role, he will be responsible for general business activities and assisting the Chairman & Managing Director.
The disclosure confirms that there are no relationships between directors relevant to this appointment. Additionally, it was stated that Jain is not debarred from holding the office of Whole-time Director by any SEBI order or other authority.
AGM outcomes and voting results
The meeting, conducted via Video Conferencing from the registered office in Itarsi, commenced at 2:00 pm and concluded at 2:20 pm. A quorum was established with 25 members participating through the virtual platform, satisfying the requirement of at least 15 members present.
The Board placed four items before the shareholders, including the adoption of financial statements for FY26 and other personnel appointments. The voting results were declared on September 29, 2026.
| Resolution | Votes Polled | In Favour | Against | % In Favour |
|---|---|---|---|---|
| Item 1 (Ordinary) | 13,49,289 | 13,49,288 | 1 | 99.9999% |
| Item 2 (Ordinary) | 13,49,289 | 13,49,288 | 1 | 99.9999% |
| Item 3 (Ordinary) | 13,49,289 | 13,49,288 | 1 | 99.9999% |
| Item 4 (Special) | 13,49,289 | 13,49,288 | 1 | 99.9999% |
Total shares outstanding stood at 37,47,000. The total votes polled across all resolutions represented approximately 36% of the outstanding share capital. CS Ishan Jain served as the scrutinizer for the voting process.
Historical Stock Returns for Natraj Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.97% | -1.23% | -0.82% | +8.40% | -0.32% | -34.91% |
How will Sharad Kumar Jain's continued leadership influence Natraj Proteins' strategic expansion in the soya processing sector over the next three years?
What specific operational efficiencies or cost-saving measures is the board expecting to see from the renewed executive mandate starting October 2026?
Given the low voter turnout of approximately 36%, what steps might the company take to improve shareholder engagement and liquidity in future AGMs?
































